Myriad Genetics (MYGN) Net Margin (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Net Margin of 17.02% for Q1 2026, down 1696.0% year-over-year from 1.07% in Q1 2025, and down 351.89% quarter-over-quarter from 3.77% in Q4 2025.
Myriad Genetics (MYGN) Net Margin (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Net Margin for 18 consecutive years, with 17.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin fell 1696.0% year-over-year to 17.02%; the TTM figure through Mar 2026 stood at 48.24% (down 3604.0% YoY), while the FY2025 annual figure was 44.38%, down 2918.0% from the prior year.
- Net Margin fell to 17.02% in Q1 2026 per MYGN's latest filing, from 3.77% in the prior quarter.
- Across five years, Net Margin topped out at 0.05% in Q1 2025 and bottomed at 155.09% in Q2 2025.
- Historically, Net Margin has averaged 26.93% across 5 years, with a median of 17.02% in 2026.
- Annual changes were most pronounced in 2024 — Net Margin jumped 4592 bps — and 2025, when it tumbled 13774 bps.
- Myriad Genetics' Net Margin stood at 23.79% in 2022, then soared by 33 bps to 15.87% in 2023, then dropped by 27 bps to 20.18% in 2024, then jumped by 81 bps to 3.77% in 2025, then plunged by 352 bps to 17.02% in 2026.
- Business Quant data shows MYGN's Net Margin at 17.02% in Q1 2026, 3.77% in Q4 2025, and 13.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 13.89% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 27.82% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 18.47% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 5.52% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.22% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.86% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 22.67% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.65% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -17.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.02% |
| Dec 31, 2025 | -3.77% |
| Sep 30, 2025 | -13.32% |
| Jun 30, 2025 | -155.09% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | -20.18% |
| Sep 30, 2024 | -10.36% |
| Jun 30, 2024 | -17.35% |
| Mar 31, 2024 | -12.86% |
| Dec 31, 2023 | -15.87% |
| Sep 30, 2023 | -31.94% |
| Jun 30, 2023 | -63.27% |
| Mar 31, 2023 | -30.19% |
| Dec 31, 2022 | -23.79% |
| Sep 30, 2022 | -22.44% |
| Jun 30, 2022 | -7.86% |
| Mar 31, 2022 | -12.43% |
| Dec 31, 2021 | -4.73% |
| Sep 30, 2021 | 14.70% |
| Jun 30, 2021 | -2.48% |